Our Team


Sally Baron-HayDr Sally Baron-Hay

Dr Baron-Hay is physician whose main area of interest is in the management of patients diagnosed with breast and gynaecological malignancies.

She participates in the Multidisciplinary care of theses malignancies attending weekly multidisciplinary meetings. These meetings are attending also by radiologists, pathologists, surgeons, radiotherapists, clinical nurse specialists and allied health care professionals.

Her laboratory research interests are discovering new biomarkers of ovarian cancer and their prognostic significance. She also actively participates in clinical trials in breast and gynaecological malignancies. These trials involve the use of new drugs investigating activity in these malignancies as well as trials designed to improve the quality of life of patients. She is actively involved in teaching, both medical students and allied health professional. 

Dr Baron-Hay has admitting rights to North Shore Private Hospital and administers chemotherapy treatments through the Northern Cancer Institute at the hospital.

Associate Professor David BellAssociate Professor, David Bell

Associate Prof. David Bell is currently Senior Staff Specialist, Medical Oncology at Royal North Shore Hospital with responsibility for the Medical Oncology Unit. Malignancies include breast, lung, colon and rectum, testicular, sarcoma, renal, melanoma, lymphoma, head and neck and brain.

He is a Visiting Medical Oncologist at North Shore Private Hospital, Manly Waters Private and Armidale Base Hospital.

Dr Bell is also Clinical Senior Lecturer in Medicine at the University of Sydney and has conducted both clinical and laboratory research work which has been widely published. He is also Associate Professor in Rural medicine at the University of New England. He is principle researcher in numerous studies covering aspects of lung, breast, ovarian, soft tissue, skin and renal cancer as well as investigations of multidrug resistance and drugs of potential patient benefit.

Dr Bell has been an invited speaker at numerous national and international forums including the USA, Canada, Hong Kong, Singapore, France and Germany.

Professor Stephen ClarkeProfessor Stephen Clarke

Stephen Clarke is a medical oncologist, pharmacologist and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers and pharmacology. He is a medical oncologist at the Northern Cancer Institute and Royal North Shore Hospital, Director of Cancer Services at Northern Sydney Local Health District and Professor of Medicine at the University of Sydney.

Prof Clarke completed his medical degree at the University of Sydney in 1983 and an FRACP in Medical Oncology at Royal North Shore Hospital in 1990. He then completed a PhD at the University of London at the Institute of Cancer Research / Royal Marsden Cancer Hospital. Professor Clarke returned from the UK in 1994 and has worked at Westmead, Nepean, Concord and Royal Prince Alfred Hospitals prior to returning to Royal North Shore Hospital in 2010. He obtained an MD from the University of Sydney in 2011.

Stephen was awarded an OAM in the Australia Day Honours in 2011 for services to medicine in the disciplines of oncology and pharmacology. He was also awarded the Eric Susman Prize from the Royal Australasian College of Physicians in 2013. In 2015 he was elected to the newly created Australian Academy of Health and Medical Science. He was also elected to be an inaugural member of Best Doctors in Australia and New Zealand in 2012.

Stephen is Head of the NSW committee of the RACP and is Oncology Advisor to the Department of Veterans Affairs as well as a Member of the Repatriation Pharmaceutical Review Committee. He has received over $25 million in competitive research funding, which has produced over 260 publications, leading to more than 10000 citations.

Associate Professor Nick PavlakisAssociate Professor, Nick Pavlakis
Medical Oncology

A/Prof Nick Pavlakis underwent undergraduate medical training at the University of NSW and graduated in 1991. He underwent general medical training and subsequent advanced training in Medical Oncology at Royal North Shore Hospital, completing FRACP in 1997. He then spent 3 years completing a PhD in new cancer drug development involving an Australian developed anti-angiogenic compound PI-88 (Progen Industries and ANU); and a Masters of Clinical Epidemiology through the University of Sydney. He has worked in private oncology practice since 1998 and has been a practice member of the Northern Cancer Institute since 2001. He is current Chair of the Lung Cancer Group of the Clinical Oncologic Society for Australa (COSA), and is Regent for Australasia for the International Association for the Study of Lung Cancer (IASLC).

He is an academic medical oncologist, having published journal manuscripts in his interest areas (lung cancer, mesothelioma, NETS, kidney cancer, gastric cancer, colorectal cancer and bisphosphonate therapy, is conducting ongoing collaboratve clinical research ((Australasian Gastro-intestinal Trials Group (AGITG), ALTG,  Australia and NZ Urologic and Prostate Cancer Trials Group (ANZUP)) and translational research with the Bill Walsh Cancer Research Laboratories/Kolling Institute.

Dr Connie DiakosDr Connie Diakos
Medical Oncology

Dr Connie Diakos is a medical oncologist specialising in gastrointestinal, breast and gynaecological cancers. She holds a PhD in platinum anti-cancer drug mechanism of action from the University of Sydney, and is an active researcher investigating the causes and consequences of inflammation in cancer in the Bill Walsh Translational Cancer Research Laboratory at the Kolling Institute of the University of Sydney.

Dr Diakos completed an FRACP in Medical Oncology in the Royal Prince Alfred Hospital network. She is a Staff Specialist at Royal North Shore Hospital and holds admitting rights to North Shore Private Hospital and actively participates in the multidisciplinary teams at Royal North Shore Hospital in her specialist tumour groups. She is involved in teaching of medical students, junior medical officers and physician trainees at Royal North Shore Hospital, and the supervision of research students at the University of Sydney.

Dr Naomi MackinlayDr Naomi Mackinlay

Naomi Mackinlay is a clinical haematologist who specialises in all areas of malignant and non-malignant haematology, with particular interests in Non Hodgkins Lymphoma, Hodgkins disease, Myeloma, autologous stem cell transplantation and also blood clotting disorders and haematological disorders in pregnancy.

Naomi graduated with first class honours from the University of Sydney in 1990 and was awarded membership of the Royal Australasian College of Physicians and the Royal Australasian College of Pathologists in 1997 after training at both Royal North Shore and Royal Prince Alfred Hospitals. She works as a Senior Staff Specialist in the Department of Haematology and Bone Marrow Transplantation at Royal North Shore Hospital and is actively involved in clinical trials and research. Naomi also lectures for the University of Sydney Graduate Medical Programme.

Throughout this time, Naomi has also worked in solo private practice in clinical haematology on the Northern Beaches of Sydney, maintaining strong links with Mona Vale Hospital where she has previously worked as a Visiting Medical Officer. Naomi moved her practice to the Northern Cancer Institute at Frenchs Forest almost 5 years ago.

Laurence KriegerDr Laurence E M Krieger

Dr Laurence Krieger graduated with honours from the University of Bristol (U.K.) in 2002 and moved to Australia in 2005. He completed Specialist training with a particular interest in thoracic urogenital and neurological malignancy, under Associate Professor Nick Pavlakis alongside Dr. Helen Wheeler at Royal North Shore Hospital.

In 2010, he completed a Fellowship in renal, prostate and thoracic oncology with Dr. Peter Harper and Dr. Simon Chowdhury at Guys’ and St Thomas’ Hospital in London. During that time, he remained active in undergraduate and postgraduate teaching, phase 1 and 3 clinical trials, in addition to establishing the Guys and St Thomas’ Thymoma Database and Registry. 

On returning to Sydney in 2011, his interest in research continues as the Director of Clinical Trials for the Riverina Cancer Care Centre and clinical trials clinic at Royal North Shore Hospital.

Dr Adrian LeeDr Adrian Lee
Medical Oncology

Dr Lee is a medical oncologist who has completed his training at Royal North Shore Hospital and has a particular interest in neuro-oncology.  He has recently completed a neuro-oncology fellowship under the supervision of Dr Helen Wheeler and is currently furthering his research in malignant brain tumours and clotting through the Bill Walsh Translational Cancer Research Laboratory at the Kolling Institute, University of Sydney with the support of a scholarship from the Rebecca Cooper Foundation.  Dr Lee is also a visiting medical officer at Armidale Hospital where he supervises and co-ordinates the care of general oncology patients in the Armidale region.

He has been the senior medical registrar at Royal North Shore Hospital (2012 -2013) with ongoing involvement in the training of basic physician trainees.  In addition, Dr Lee is also heavily involved with teaching of medical students of the Sydney Medical School - Northern - both in clinical tutorials,lectures and examination and basic science research projects.

Gavin MarxA/Prof Gavin Marx
Medical Oncology

A/Prof Gavin Marx graduated from the University of New South Wales with honours in 1993.  He obtained his fellowship with the RACP in 2000, and completed his specialist training in medical oncology at Royal North Shore Hospital and Prince of Wales Hospitals.  He subsequently completed a 2 year fellowship at Guy's Hospital, U.K.  A/Prof Marx currently has a private practice at the Sydney Adventist Hospital and Northern Cancer Institute in Frenchs Forest. He established and is currently the director of the San Oncology Clinical Trials Unit.

Gavin is an associate professor of medicine at Sydney University and is involved in teaching at an undergraduate and post-graduate level. A/Prof Marx is actively involved in clinical research, with a number of peer reviewed publications. He has a particular interest in the management of patients with hormone refractory prostate cancer, breast cancer and gastro-intestinal malignancies.Gavin is an active member of ASCO, MOGA, AGITG, ANZUP, ANZBCTG, UOP, and COSA.

Paul de SouzaProf Paul de Souza
Medical Oncology

Professor Paul de Souza has been a practicing medical oncologist for more than 20 years, having obtained the FRACP in 1992. He trained in medical oncology at St George and Prince of Wales Hospitals, and was Research Assistant Professor at the University of Virginia (1994-1997) before working at Wollongong (1997-1999) and St George Hospitals (1999-2010). In 2010, he was appointed Foundation Professor of Medical Oncology at University of Western Sydney and a medical oncologist at Liverpool Hospital. He has sub-speciality interests in genitourinary cancer, brain cancer and rare cancers such as sarcoma. He runs a laboratory at the Ingham Institute, Liverpool Hospital, and conducts many clinical trials including Phase I trials. He has been teaching medical students, residents, registrars and advanced trainees over many years, in Australia and in the USA. He continues to supervise medical student research, Masters research students, and PhD students. His private practice is conducted at Southside Cancer Centre Miranda, St George Private, and Mater Hospital in North Sydney.

Diana LearoydA/Prof Diana Learoyd

A/Prof Diana Learoyd is a clinical academic Endocrinologist (NSPH and RNSH) and Associate Professor at Sydney Medical School. Diana trained at RNSH and spent a year at Kings College Hospital in London in 1991. She completed a PhD in the Kolling Institute in 1999 in the genetics of thyroid cancer, and of MEN2 and set up a thyroid cancer clinical database at RNSH with a NSWCI grant. She had a major role in the TKI clinical trials run at RNSH, for both differentiated and medullary thyroid cancer (DTC and MTC) patients. Diana did help run the endocrine tumour MDT, at Royal North Shore Hospital in collaboration with the Department of Endocrine Surgery. She has a busy clinical practice with a special interest in thyroid disease of all types but she does see all types of general endocrinology cases at NCI, including patients with endocrine disorders in pregnancy.

Christopher ArthurDr Christopher Arthur

Christopher Arthur, (MBBS (hons - UNSW), FRACP, FRCPA) holds appointments as a senior staff specialist in Haematology at Royal North Shore Hospital and consultant haematologist at the Northern Cancer Institute (St. Leonards and Frenchs Forest).

Dr. Arthur earned his medical degree from the University of New South Wales and completed his basic specialist physician training at Royal North Shore Hospital. He undertook specialist training in haematology at Royal North Shore Hospital and then completed haematology training in London. While in London he served in a diversity of posts at The Hammersmith Hospital, Royal Free Hospital, Great Ormond Street Children's hospital and the North Middlesex hospital. He gained valuable experience in Bone Marrow transplantation and Chronic Myeloid Leukemia under the guidance of Prof John Goldman at the Royal Imperial College Hammersmith Hospital. Research currently being conducted by Dr. Arthur includes the study of novel treatments for chronic myeloid leukemia, acute myeloid leukemia, lymphoma, myeloma, hematopoietic stem cell transplantation, and reduced-intensity allogeneic transplants. He is also an active participant in studies by the Australasian Leukaemia and Lymphoma Group. Dr. Arthur’s interests also include the use of telehealth systems for remote patient care and consultation, and the development of electronic health records and haematology/oncology software management systems for better patient care. He is a member of the Haematology Society of Australasia & New Zealand, European Haematology Association, American Society of Hematology, American Society of Blood and Marrow Transplantation. He has published nearly 50 scientific articles.

Dr Victoria PecheyDr Victoria Pechey

Dr Victoria Pechey studied medicine at UNSW, graduated in 2003. She undertook prevocational and physician training at Royal North Shore Hospital. She has completed Haematology training with the Royal Australasian College of Physicians and the Royal College of Pathologists of Australia in 2014 based at Royal North Shore Hospital but did her final year of advanced training in the UK (Belfast City Hospital, Northern Ireland). She then commenced work as a Consultant Haematologist in Belfast for 6 months before returning to Australia to complete a fellowship in Bone Marrow Transplantation at Royal North Shore Hospital. After returning to Australia she started working as a Staff Specialist at Royal North Shore Hospital in a locum capacity for 9 months before returning to the UK. She worked in a district general hospital in Northern Ireland as a Haematologist for 4 months before taking her time off for maternity leave. She had returned to Australia on a permanent basis now and working as a part-time staff specialist haematologist at RNSH. Also, she works part-time at the Northern Clinical School of the University of Sydney as a senior lecturer in medicine and heavily involved with the medical students. She have been involved in a number of research projects mostly around allogeneic haematopoietic stem cell transplantation but the main focus of her career is clinical work and education.

She has a broad interest in general haematology with a focus on malignant haematology. She is happy to be contacted for phone advice and for urgent referrals.

Dr Mustafa KhasrawDr Mustafa Khasraw
Medical Oncology

Associate Professor Mustafa Khasraw is a medical oncologist at Royal North Shore Hospital and the Northern Cancer Sydney, St Leonards, Sydney. He is also a senior research fellow and clinical lead at the NHMRC Clinical Trials Centre of The University of Sydney, cancer research fellow at Deakin University with leading role in several clinical and translational laboratory programs.

He completed his medical oncology training at Royal North Shore Hospital in Sydney and he undertook subsequent oncology fellowship training in the US (2010-2011) at Memorial Sloan-Kettering Cancer Centre in New York. After his fellowship in New York he returned to practice in Melbourne and Geelong (2011-2015) where he was the clinical lead of the Haematology and Oncology Clinical Trials at Andrew Love Cancer Centre in Geelong and as a Medical Oncologist at Geelong and Royal Melbourne Hospitals.

He is a member of several research committees and the coordinating principal investigator for a number of multi-centre clinical trials.

Dr Lina PuglianoDr Lina Pugliano
Medical Oncology

Lina is a medical oncologist specialising in the management of breast cancer. Working clinically at The Northern Cancer Institute at St Leonards, she is known to be an avid volunteer in the Australian, New Zealand breast cancer trial groups and is actively involved in clinical trials.

Accompanying her teaching role at the University of Sydney, Lina has also taken up a research role. Her areas of research centre on the impact of obesity in breast cancer and lifestyle interventions.

She was a research fellow at the Institute Jules Bordet, a leading international oncological hospital and research unit in Brussels, Belgium, between the years 2011 – 2013. This research fellowship in breast cancer allowed her to collaborate with international leaders in breast cancer research, gaining first hand experience in intellectual insights into breast cancer, new treatment and drug development.

Receiving her medical training at the prestigious Royal Prince Alfred contributes to her impressive history of knowledge and practical experience. Her qualifications include a Bachelor of Medicine and a Bachelor of Surgery both obtained at the University of Sydney and a Bachelor of Advanced Science (Honours) at the University of New South Wales.

Lina is a passionate oncologist focused on both treatment and caring for her patients. Her extensive skills and knowledge on breast cancer allow her to fully facilitate for her patients and most importantly, provide the support that they require.

Dr Malinda ItchinsDr Malinda Itchins
Medical Oncology
BMedSci; MBBS (Hons1); FRACP; PhD candidate

Dr Malinda Itchins underwent her medical oncology training at the University of Tasmania, in her home state, graduating in 2009 with first class honours. She completed her physician training followed by FRACP in Medical Oncology at Royal North Shore Hospital in 2016.  In 2017 she enrolled as a Doctor of Philosophy in Medicine through the Bill Walsh Translational Cancer Research Laboratory at the University of Sydney’s Kolling Institute, with the support of the Ilse Schnell Cancer Research Postgraduate Scholarship and NSW Health PhD Scholarship. Her research is in investigating patterns of drug resistance in ALK rearranged non-small cell lung cancer. She is also involved in research in pancreatic cancer.

Malinda’s main areas of interest are in treating thoracic (spinal), gastrointestinal, lung and genitourinary (genital and urinary) cancers. She is an active member of the Australasian Lung Trials Group and is an appointed Visiting Medical Officer at North Shore Private Hospital.

Dr Tristan BarnesDr Tristan Barnes
Medical Oncologist
BSc (Med) MB BS (Hons I) FRACP

Dr Tristan Barnes is a medical oncologist with an interest in thoracic (lung) and breast cancers. She graduated from medicine at the University of New South Wales in 2006 with first class honours. She completed her general medical training in 2010 at Prince of Wales Hospital and went on to do medical oncology at Royal North Shore, St George and Prince of Wales Hospitals, completing her training in 2015. She did a clinical trials fellowship at Royal North Shore Hospital in 2016. She then went to Princess Margaret Cancer Centre in Toronto, Canada to complete a clinical research fellowship in Thoracic and Breast Cancer with world renowned mentors.

She plans to continue her academic and teaching interests through the University of Sydney. She works at the Northern Beaches Cancer Service at Manly Hospital and will work at the new Northern Beaches Hospital when it opens in late 2018. She regularly attends the Breast Cancer and Lung Cancer multidisciplinary meetings at Royal North Shore Hospital and attends other tumour stream meetings as needed to ensure her patients are discussed in a team of specialised doctors. She also has admitting rights at North Shore Private Hospital.

She has an interest in clinical trials and her research and publications are in the efficacy and value of novel drugs, the use of patient reported outcome questionnaires, costs involved with new investigations to detect lung cancer resistance and extended hormone therapy in breast cancer.

She has a compassionate, holistic approach; is an excellent communicator and is devoted to personalised patient care.